Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
CHINA SHENGMU ORGANIC MILK LIMITED
中 國 聖 牧 有 機 奶 業 有 限 公 司
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 1432)
INTERIM RESULTS ANNOUNCEMENT
FOR THE SIX-MONTH PERIOD ENDED 30 JUNE 2019
FINANCIAL HIGHLIGHTS
For the six-month period ended 30 June | |||
2019 | 2018 | Movements | |
RMB'000 | RMB'000 | ||
Revenue | 1,420,582 | 1,400,105 | 1.5% |
Gross profit | 517,404 | 434,880 | 19.0% |
Profit/(loss) from continuing operations | 32,233 | (722,170) | 754,403 |
Loss from a discontinued operation | (52,991) | (556,033) | 503,042 |
Loss for the period | (20,758) | (1,278,203) | 1,257,445 |
In this announcement "we", "us" and "our" refer to the Company (as defined below) and where the context otherwise requires, the Group (as defined below).
Translated English names of Chinese natural persons, legal persons, governmental authorities, institutions or other entities for which no official English translation exists are unofficial translations for identification purpose only.
- 1 -
The board (the "Board") of directors (the "Directors") of China Shengmu Organic Milk Limited (the "Company" or "China Shengmu") herein presents the unaudited consolidated interim results of the Company and its subsidiaries (the "Group" or "Shengmu") for the six- month period ended 30 June 2019 (the "2019 Interim Period" or the "Interim Period"), together with the comparative figures for the six months period ended 30 June 2018 (the "2018 Interim Period") as follows:
INTERIM CONDENSED CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME
For the six months ended 30 June | |||||||
Notes | 2019 | 2018 | |||||
(Unaudited) | (Unaudited) | ||||||
Restated* | |||||||
RMB'000 | RMB'000 | ||||||
CONTINUING OPERATIONS | |||||||
REVENUE | 3 | 1,200,780 | 969,370 | ||||
Cost of sales | (756,195) | (682,506) | |||||
Gross profit | 444,585 | 286,864 | |||||
Loss arising from changes in fair value less | |||||||
costs to sell of biological assets | (163,495) | (886,071) | |||||
Other income and (losses)/gains | (16,472) | 16,351 | |||||
Selling and distribution expenses | (17,809) | (27,583) | |||||
Administrative expenses | (57,336) | (37,148) | |||||
Impairment losses on financial and | |||||||
contract assets, net | (12,802) | (1,016) | |||||
Finance costs | (122,860) | (70,650) | |||||
Share of losses of associates | (21,361) | (3,398) | |||||
PROFIT/(LOSS) BEFORE TAX FROM | |||||||
CONTINUING OPERATIONS | 32,450 | (722,651) | |||||
Income tax (expense)/credit | 4 | (217) | 481 | ||||
PROFIT/(LOSS) FOR THE PERIOD | |||||||
FROM CONTINUING OPERATIONS | 32,233 | (722,170) | |||||
DISCONTINUED OPERATION | |||||||
Loss for the period from | |||||||
a discontinued operation | 5 | (52,991) | (556,033) | ||||
LOSS FOR THE PERIOD | (20,758) | (1,278,203) | |||||
- 2 -
INTERIM CONDENSED CONSOLIDATED STATEMENT OF | |||||||
COMPREHENSIVE INCOME (CONTINUED) | |||||||
For the six months ended 30 June | |||||||
Note | 2019 | 2018 | |||||
(Unaudited) | (Unaudited) | ||||||
RMB'000 | Restated* | ||||||
RMB'000 | |||||||
Profit/(loss) attributable to: | |||||||
Owners of the parent | (73,501) | (1,158,623) | |||||
Non-controlling interests | 52,743 | (119,580) | |||||
(20,758) | (1,278,203) | ||||||
LOSS PER SHARE ATTRIBUTABLE | |||||||
TO ORDINARY EQUITY HOLDERS | |||||||
OF THE PARENT | 7 | ||||||
Basic | |||||||
- For loss for the period | (RMB0.012) | (RMB0.182) | |||||
- For loss for continuing operations | (RMB0.003) | (RMB0.095) | |||||
Diluted | |||||||
- For loss for the period | (RMB0.012) | (RMB0.182) | |||||
- For loss for continuing operations | (RMB0.003) | (RMB0.095) | |||||
Exchange differences on translation | |||||||
of foreign operations | (1,903) | (4,198) | |||||
Net other comprehensive loss that may | |||||||
be reclassified to profit or loss in | |||||||
subsequent periods | (1,903) | (4,198) | |||||
OTHER COMPREHENSIVE LOSS | |||||||
FOR THE PERIOD, NET OF TAX | (1,903) | (4,198) | |||||
TOTAL COMPREHENSIVE | |||||||
LOSS FOR THE PERIOD | (22,661) | (1,282,401) | |||||
Profit/(loss) attributable to: | |||||||
Owners of the parent | (75,404) | (1,162,821) | |||||
Non-controlling interests | 52,743 | (119,580) | |||||
(22,661) | (1,282,401) | ||||||
- Certain amounts shown here do not correspond to the interim condensed consolidated financial information for the six months ended 30 June 2018 and reflect adjustments made. Refer to note 2 to the interim condensed consolidated financial information for the six months ended 30 June 2019.
- 3 -
INTERIM CONDENSED CONSOLIDATED STATEMENT OF
FINANCIAL POSITION
As at | |||||||
30 June | 31 December | ||||||
Note | 2019 | 2018 | |||||
(Unaudited) | (Audited) | ||||||
RMB'000 | RMB'000 | ||||||
NON-CURRENT ASSETS | |||||||
Property, plant and equipment | 2,044,931 | 2,087,045 | |||||
Right-of-use assets | 20,074 | - | |||||
Prepaid land lease payments | - | 18,845 | |||||
Other intangible assets | 10,813 | 11,463 | |||||
Investments in associates | 199,118 | 90,328 | |||||
Biological assets | 8 | 2,568,631 | 2,667,427 | ||||
Prepayments, other receivables and other assets | 88,074 | 1,014 | |||||
Long term receivables | 11,794 | 11,516 | |||||
Deferred tax assets | 410 | 410 | |||||
Other non-current assets | 11,289 | 9,930 | |||||
Total non-current assets | 4,955,134 | 4,897,978 | |||||
CURRENT ASSETS | |||||||
Inventories | 346,496 | 604,060 | |||||
Biological assets | 8 | 3,778 | 7,492 | ||||
Trade and bills receivables | 225,871 | 246,715 | |||||
Prepayments, other receivables and other assets | 769,809 | 599,092 | |||||
Pledged deposits | 46,887 | 150,617 | |||||
Cash and bank balances | 250,235 | 74,052 | |||||
Assets of a disposal group classified as held | |||||||
for sale | - | 978,355 | |||||
Total current assets | 1,643,076 | 2,660,383 | |||||
- 4 -
INTERIM CONDENSED CONSOLIDATED STATEMENT OF
FINANCIAL POSITION (CONTINUED)
As at | ||||||
30 June | 31 December | |||||
2019 | 2018 | |||||
(Unaudited) | (Audited) | |||||
RMB'000 | RMB'000 | |||||
CURRENT LIABILITIES | ||||||
Trade and bills payables | 989,827 | 997,085 | ||||
Other payables and accruals | 658,519 | 486,235 | ||||
Derivative financial instruments | 5,779 | 81,238 | ||||
Interest-bearing bank and other borrowings | 1,999,288 | 2,218,864 | ||||
Liabilities directly associated with the assets | ||||||
classified as held for sale | - | 790,006 | ||||
Total current liabilities | 3,653,413 | 4,573,428 | ||||
NET CURRENT LIABILITIES | (2,010,337) | (1,913,045) | ||||
TOTAL ASSETS LESS CURRENT | ||||||
LIABILITIES | 2,944,797 | 2,984,933 | ||||
NON-CURRENT LIABILITIES | ||||||
Interest-bearing bank and other borrowings | 43,665 | 49,518 | ||||
Long term payables | 57,205 | 56,528 | ||||
Total non-current liabilities | 100,870 | 106,046 | ||||
Net assets | 2,843,927 | 2,878,887 | ||||
EQUITY | ||||||
Equity attributable to owners of the parent | ||||||
Share capital | 50 | 50 | ||||
Reserves | 2,018,063 | 2,017,863 | ||||
2,018,113 | 2,017,913 | |||||
Non-controlling interests | 825,814 | 860,974 | ||||
Total equity | 2,843,927 | 2,878,887 | ||||
- 5 -
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
China Shengmu Organic Milk Ltd. published this content on 03 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 September 2019 13:29:26 UTC